| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |